Inspire Trust Company’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.55M Buy
162,000
+12,000
+8% +$319K 0.7% 62
2025
Q4
$3.73M Hold
150,000
0.61% 74
2025
Q3
$3.82M Buy
150,000
+20,000
+15% +$494K 0.7% 69
2025
Q2
$3.15M Buy
130,000
+25,000
+24% +$583K 0.65% 74
2025
Q1
$2.66M Buy
105,000
+4,292
+4% +$112K 0.63% 72
2024
Q4
$2.67M Buy
100,708
+8,000
+9% +$217K 0.68% 66
2024
Q3
$2.68M Buy
92,708
+14,891
+19% +$434K 0.74% 59
2024
Q2
$2.18M Buy
77,817
+22,609
+41% +$622K 0.72% 59
2024
Q1
$1.53M Buy
55,208
+26,875
+95% +$746K 0.86% 43
2023
Q4
$816K Buy
+28,333
New +$856K 0.84% 46

Other funds holding PFE

Inspire Trust Company's PFE Position: Q1 2026 in Review

Inspire Trust Company increased its Pfizer (PFE) stake by 8% in Q1 2026, buying an estimated $319K and bringing the position to 162,000 shares worth $4.55M. The position accounts for 0.7% of the portfolio, ranked #62.

Inspire Trust Company first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Inspire Trust Company held 162,000 shares of Pfizer worth $4.55M as of Q1 2026.
  • Inspire Trust Company bought 12,000 Pfizer shares in Q1 2026, an estimated $319K.
  • Pfizer made up 0.7% of Inspire Trust Company's portfolio in Q1 2026, its #62 holding.
  • Inspire Trust Company first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Inspire Trust Company's 13F filing for Q1 2026, filed 12 May 2026.